ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Portland, OR, USA:

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Portland, Oregon, United States and 10 other locations

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Biological: aglatimagene besadenovec

Phase 2

Candel Therapeutics

Portland, Oregon, United States and 22 other locations

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110 in Combination with Abiraterone

Phase 1

Arvinas
Arvinas

Portland, Oregon, United States and 17 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Portland, Oregon, United States and 53 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Aglatimagene besadenovec + valacyclovir
Biological: Placebo + valacyclovir

Phase 3

Candel Therapeutics

Portland, Oregon, United States and 72 other locations

with abiraterone acetate plus prednisone has on the patient and the prostate cancer. Abiraterone acetate plus prednisone are drugs ...

Active, not recruiting
Prostate Cancer
Drug: Ipilimumab

Phase 1, Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Portland, Oregon, United States and 2 other locations

All patients will be required to have a biopsy of a metastatic tumor deposit at study entry. Pembrolizumab will be administered at a dose of 200 mg a...

Enrolling
Prostate Cancer Metastatic
Prostate Cancer
Biological: Fecal microbiota transplant
Drug: Pembrolizumab

Phase 2

Julie Graff, MD

Portland, Oregon, United States

Pembrolizumab will be administered at a dose of 200 mg will be administered as a 30 minute IV infusion every 3 weeks. Enzalutamide will be administer...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: Pembrolizumab

Phase 2

Mark Garzotto, MD

Portland, Oregon, United States

This clinical trial investigates the change in prostate-specific membrane antigen (PSMA) expression in response to hormonal therapy in both, ...

Not yet enrolling
Prostate Adenocarcinoma
Castration Sensitive Prostate Cancer
Drug: Piflufolastat
Other: Electronic Health Record Review

Phase 4

OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Portland, Oregon, United States

Emission Tomography (PET) in patients with biochemical recurrence of prostate cancer (BCR) and a negative Prostate Specifi...

Enrolling
Prostate Cancer
Drug: Fluciclovine PET/CT

Phase 4

OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Portland, Oregon, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems